Bull & Bear

Figures converted from INR at historical FX rates — see data/company.json.fx_rates. Ratios, margins, and multiples are unitless and unchanged.

Bull and Bear

Verdict: Lean Long, Wait For Confirmation — the backward-looking fundamentals are clearly top-quartile (FY26 revenue $439M +22%, PAT $75M +30%, FCF $81M at 107% of PAT, ROCE 34.8%, 0 forensic red flags) and the $14.19 print at 18× TTM is the cheapest entry in five years once the 1:1 bonus issue (allotted 16 Mar 2026) is unwound. But the bear is right that the moat's durable variable — does eClerx capture AI productivity as new outcome-priced revenue or cede it as T&M price concessions — is not yet measurable, and a 91% time-and-materials book with flat revenue-per-employee at ~$21.9K for three years is structurally exposed if it cedes. The single tension that decides the trade is therefore monetisation of AI productivity, not the bonus-issue optics or the forensic Watch score. A quantified Agentic-AI revenue line (even ≥3% of group) plus an FY27 operating EBITDA print held inside the 25–28% band would validate the bull setup; the absence of either through H1 FY27, especially against an adopted FCC NPRM hitting the 45%-of-revenue Customer Operations vertical, would invert the conclusion.

Bull Case

Bull target $21.00, method 22× FY27E EPS ~$0.96 (consensus PAT growth 15–17% on FY26 $75M divided by ~94 million post-bonus shares), timeline 12–18 months — anchored to the company's own five-year average multiple, between Emkay's $18.90 (~20×) and Nomura's $23.31 (~25×). Disconfirming signal: two consecutive quarters of operating EBITDA margin below 24% combined with top-10 client concentration ticking back above 62%.

Bear Case

Bear downside target $9.45, method 12× degraded FY27 EPS ~$0.79 (Genpact 10× anchor + ~20% quality premium; revenue growth decelerates to ~10%, op EBITDA margin slips to 22–23%, FCF/PAT mean-reverts to ~90% as unbilled drift normalises), timeline 12–18 months. Cover signal: two consecutive quarters of revenue/employee rising >10% YoY and a quantified agentic-AI revenue disclosure ≥5% of group revenue.

The Real Debate

Verdict

Lean Long, Wait For Confirmation. Bull carries more weight on the backward evidence — FY26 is a record print on revenue, PAT, FCF, ROCE, and capital return, the forensic verdict is clean (22/100 Watch, zero red flags, unqualified PWC opinion in year one), and the 18× entry multiple plus bonus-issue mechanics make the −72% headline materially overstate the fundamental damage. The single most important tension is whether AI productivity flows to eClerx as new outcome-priced revenue or to clients as T&M price concessions — and on this, the bear is correct that the evidence does not yet exist: revenue/employee has been flat at ~$21.9K for three years, 91% of revenue is T&M, and no AI revenue line has been disclosed while a global peer separately reports $1.2B. The bear could still be right because the FCC NPRM is now adopted (not tail), Capgemini-WNS is a real Tier-1 flanking move inside the BFSI niche, and a three-year flat output-per-head is consistent with quiet deflation that only shows in the P&L after the lag. The durable thesis breaker is two consecutive quarters of operating EBITDA margin below 24% with no quantified Agentic-AI revenue disclosure through H1 FY27 — that combination converts AI deflation and integrator wallet-share take from narrative into reported income. The near-term evidence marker — the first quantified outcome-priced revenue print on the Q1 or Q2 FY27 call — is the lower-stakes observable that confirms the bull setup if it arrives; its absence alone is not yet the breaker, but does extend the "Wait" portion of the verdict.